Jalal Abbas, MD
Internal Medicine · Sun City West, AZNPI 1205895034
Payments from drug & device makers
Across 610 payments — averaging $7859.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$2.3M
- Novartis$697K
- AstraZeneca$402K
- Janssen Research & Development, LLC$388K
- Boehringer Ingelheim$368K
- American Regent$133K
- plus $491K from 25 others
Across 10 payments — averaging $5257.27 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$49K
- Ardelyx, Inc.$4K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 72 | $2,315,717 |
| Novartis | 32 | $697,463 |
| AstraZeneca | 22 | $401,535 |
| Janssen Research & Development, LLC | 54 | $387,756 |
| Boehringer Ingelheim | 30 | $367,538 |
| American Regent | 12 | $132,960 |
| Sanofi US Services Inc. | 32 | $122,123 |
| Pfizer | 40 | $90,308 |
| Ardelyx, Inc. | 44 | $82,335 |
| Kowa Research Institute, Inc. | 21 | $60,430 |
| Hikma Pharmaceuticals USA | 6 | $35,893 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | 6 | $21,700 |
| Boehringer Ingelheim Canada Ltd.ltee | 32 | $20,937 |
| Alnylam Pharmaceuticals Inc. | 4 | $19,085 |
| GSK | 9 | $17,850 |
| Boehringer Ingelheim International GmbH | 130 | $15,302 |
| Chiesi USA, Inc. | 1 | $2,250 |
| Sanofi Pasteur Inc. | 4 | $1,790 |
| Eli Lilly Export S.A. Puerto Rico Branch | 1 | $550 |
| Sanofi-aventis U.S. LLC | 16 | $221 |
| Amgen | 10 | $179 |
| Novo Nordisk | 6 | $101 |
| Amarin Pharma, Inc. | 3 | $88 |
| Merck | 6 | $74 |
| Lilly USA, LLC | 5 | $73 |
| Teva Pharmaceuticals USA, Inc. | 3 | $68 |
| Medtronic(2 entities) | 3 | $47 |
| AbbVie(2 entities) | 3 | $44 |
| Astellas Pharma US Inc | 1 | $20 |
| Vyera Pharmaceuticals, LLC | 1 | $15 |
| Abbott | 1 | $14 |
How this compares
$4,794,466 in reported general payments places this provider in the 95th percentile of 2,212 internal medicine providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Sun City West
- Yessica SachdevaMesa$13.7M
- Louise TaberPhoenix$8.5M
- Janelle WeyerChandler$5.5M
- Robert MutterperlTucson$5.3M
- Nebojsa SkrepnikTucson$4.7M
- Philip MathewTempe$4.1M
- Justin MoserScottsdale$3.9M
- Franz RischardTucson$3.7M
- Randall SeveranceChandler$3.1M
- Ernie RifferPhoenix$3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.